Skip to content

Nektar Therapeutics

US · NKTR #3017 by market cap Listed 1970
40.26 +0.35 +0.88%
Live - 5344 symbols - heartbeat 368s ago · 2026-10-08 06:54
Pre-market 39.35 -2.26%
After-hours 40.00 -0.65%
Overnight 40.20 -0.15%
Market cap
1.37B
P/B
1.52
EPS
-9.73
Reader sentiment Are you bullish or bearish on NKTR?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    TD Cowen Initiates Nektar Therapeutics(NKTR.US) With Buy Rating
    Market Newswire · 2026/3/17
  • Rating change
    Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $192
    Market Newswire · 2026/5/8
  • Rating change
    Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $123
    Market Newswire · 2026/4/7
  • Rating change
    A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $80 to $192
    Market Newswire · 2026/8/15
  • BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $178
    Market Newswire · 2026/9/30
  • William Blair Maintains Nektar Therapeutics(NKTR.US) With Buy Rating
    Market Newswire · 2026/10/2
  • Rating change
    Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $192
    Market Newswire · 2026/8/20
  • Rating change
    TD Cowen Maintains Nektar Therapeutics(NKTR.US) With Buy Rating
    Market Newswire · 2026/5/8
  • Rating change
    CCORF Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $153
    Market Newswire · 2026/7/22
  • Rating change
    Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $151
    Market Newswire · 2026/4/21
  • Jefferies Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $150
    Market Newswire · 2026/10/2
  • Rating change
    Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $123
    Market Newswire · 2026/3/16
  • Rating change
    H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Cuts Target Price to $135
    Market Newswire · 2026/4/6
  • Rating change
    CCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153
    Market Newswire · 2026/9/28
  • Rating change
    H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $165
    Market Newswire · 2026/3/17
  • Rating change
    A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $134 to $185
    Market Newswire · 2026/4/21
  • Rating change
    Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/3/13
  • Rating change
    Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $140
    Market Newswire · 2026/5/8
  • H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $185
    Market Newswire · 2026/10/3
  • Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $151
    Market Newswire · 2026/10/5

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 06:54:04 · For reference only, not investment advice and not tailored to your situation.